Treatment of human neuroblastoma SH-SY5Y cells with 1 mm1-methyl-4-phenylpyridinium (MPP
+ ) for 3 days induced production of reactive oxygen species (ROS), followed by …

… This paper presents the data that the anti-parkinson drug, rasagiline and its (S)-enantiomer
are some of the most potent neuroprotective reagents so far studied using SH-SY5Y cells. …

… -human primates, used as animal models of parkinsonism. Here we describe an increase in
α-synuclein expression in a human neuroblastoma … by the antiparkinsonian drugs, talipexole …

… , rasagiline, an anti-Parkinson drug, was found to increase the protein and mRNA levels
of glial cell line-derived neurotrophic factor (GDNF) in human neuroblastoma SH-SY5Y cells, …

… We report here that human neuroblastoma SH-SY5Y cells treated with DA undergo
autophagy before death. Autophagy is a route for the sequestration of cytoplasm to a lytic …

… This article reports that NM(R)SaI induces DNA damage in human dopaminergic neuroblastoma
SHSY5Y cells. To assess DNA damage, a single-cell gel electrophoresis (comet) assay …

… Here, we provide evidence that parkin protected human DA neuroblastoma cells by decreasing
the production of ROS and the activation of apoptotic pathways emanated from JNK. As …

… SK-N-SH human neuroblastoma cells were purchased from the American Type Cell Culture
(ATCC, Manassas, VA, USA) and were cultured in MEM supplemented with 10% FBS, 2 mM …

… , we made use of these very well characterized human neuroblastoma … drugs on the viability
of human neuroblastoma cells. We now report that several non-specific antimuscarinic drugs…

… We have studied the inducibility of CYP isozymes in human neuroblastoma SH-SY5Y cells,
treated with β-naphtoflavone (β-NF) or ethanol (EtOH) as inducers, by qRT-PCR, Western …